Relation of Vitamin E and selenium exposure to prostate cancer risk by smoking status

A review and meta-analysis

Yeunjung Kim, Jingkai Wei, Jessica Citronberg, Terryl Hartman, Veronika Fedirko, Michael Goodman

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background: Epidemiological studies of selenium and vitamin E, two antioxidants hypothesized to reduce prostate cancer risk, have shown no discernible benefit. It has been proposed, however, that tobacco smoking may modify the effect of these nutrients. Materials and Methods: We performed a meta-analysis of studies evaluating the relation of vitamin E and selenium exposure to prostate cancer risk in never smokers vs. ever smokers and, when feasible, former and current smokers. Overall and stratumspecific meta-risk ratios (meta-RRs) and 95% confidence intervals (CIs) were calculated using random-effects models. Results: A total of 21 studies have met the inclusion criteria. Meta-RR (95% CI) estimates of prostate cancer associated with vitamin E use were 1.03 (0.95-1.11) in never smokers and 0.98 (0.90-1.07) in ever-smokers. For selenium, meta- RRs were 1.09 (0.78-1.52 and 0.76 (0.60-0.96) for never and ever-smokers, respectively; however, results for current smokers were weaker than those for former smokers. Subanalyses according to different exposure assessment methods and outcome definitions produced similar results across strata. Conclusion: The association between vitamin E and prostate cancer is not modified by smoking. Selenium exposure is associated with lower prostate cancer risk among ever-smokers; however, the lack of an association for current smokers indicates that this finding needs to be interpreted with caution.

Original languageEnglish (US)
Pages (from-to)4983-4996
Number of pages14
JournalAnticancer Research
Volume35
Issue number9
StatePublished - Sep 1 2015

Fingerprint

Selenium
Vitamin E
Meta-Analysis
Prostatic Neoplasms
Smoking
Confidence Intervals
Epidemiologic Studies
Antioxidants
Odds Ratio
Outcome Assessment (Health Care)
Food

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Kim, Y., Wei, J., Citronberg, J., Hartman, T., Fedirko, V., & Goodman, M. (2015). Relation of Vitamin E and selenium exposure to prostate cancer risk by smoking status: A review and meta-analysis. Anticancer Research, 35(9), 4983-4996.
Kim, Yeunjung ; Wei, Jingkai ; Citronberg, Jessica ; Hartman, Terryl ; Fedirko, Veronika ; Goodman, Michael. / Relation of Vitamin E and selenium exposure to prostate cancer risk by smoking status : A review and meta-analysis. In: Anticancer Research. 2015 ; Vol. 35, No. 9. pp. 4983-4996.
@article{6f3b499d0a5e4b3ba1ae8ea4f05fb8af,
title = "Relation of Vitamin E and selenium exposure to prostate cancer risk by smoking status: A review and meta-analysis",
abstract = "Background: Epidemiological studies of selenium and vitamin E, two antioxidants hypothesized to reduce prostate cancer risk, have shown no discernible benefit. It has been proposed, however, that tobacco smoking may modify the effect of these nutrients. Materials and Methods: We performed a meta-analysis of studies evaluating the relation of vitamin E and selenium exposure to prostate cancer risk in never smokers vs. ever smokers and, when feasible, former and current smokers. Overall and stratumspecific meta-risk ratios (meta-RRs) and 95{\%} confidence intervals (CIs) were calculated using random-effects models. Results: A total of 21 studies have met the inclusion criteria. Meta-RR (95{\%} CI) estimates of prostate cancer associated with vitamin E use were 1.03 (0.95-1.11) in never smokers and 0.98 (0.90-1.07) in ever-smokers. For selenium, meta- RRs were 1.09 (0.78-1.52 and 0.76 (0.60-0.96) for never and ever-smokers, respectively; however, results for current smokers were weaker than those for former smokers. Subanalyses according to different exposure assessment methods and outcome definitions produced similar results across strata. Conclusion: The association between vitamin E and prostate cancer is not modified by smoking. Selenium exposure is associated with lower prostate cancer risk among ever-smokers; however, the lack of an association for current smokers indicates that this finding needs to be interpreted with caution.",
author = "Yeunjung Kim and Jingkai Wei and Jessica Citronberg and Terryl Hartman and Veronika Fedirko and Michael Goodman",
year = "2015",
month = "9",
day = "1",
language = "English (US)",
volume = "35",
pages = "4983--4996",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "9",

}

Kim, Y, Wei, J, Citronberg, J, Hartman, T, Fedirko, V & Goodman, M 2015, 'Relation of Vitamin E and selenium exposure to prostate cancer risk by smoking status: A review and meta-analysis', Anticancer Research, vol. 35, no. 9, pp. 4983-4996.

Relation of Vitamin E and selenium exposure to prostate cancer risk by smoking status : A review and meta-analysis. / Kim, Yeunjung; Wei, Jingkai; Citronberg, Jessica; Hartman, Terryl; Fedirko, Veronika; Goodman, Michael.

In: Anticancer Research, Vol. 35, No. 9, 01.09.2015, p. 4983-4996.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Relation of Vitamin E and selenium exposure to prostate cancer risk by smoking status

T2 - A review and meta-analysis

AU - Kim, Yeunjung

AU - Wei, Jingkai

AU - Citronberg, Jessica

AU - Hartman, Terryl

AU - Fedirko, Veronika

AU - Goodman, Michael

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Background: Epidemiological studies of selenium and vitamin E, two antioxidants hypothesized to reduce prostate cancer risk, have shown no discernible benefit. It has been proposed, however, that tobacco smoking may modify the effect of these nutrients. Materials and Methods: We performed a meta-analysis of studies evaluating the relation of vitamin E and selenium exposure to prostate cancer risk in never smokers vs. ever smokers and, when feasible, former and current smokers. Overall and stratumspecific meta-risk ratios (meta-RRs) and 95% confidence intervals (CIs) were calculated using random-effects models. Results: A total of 21 studies have met the inclusion criteria. Meta-RR (95% CI) estimates of prostate cancer associated with vitamin E use were 1.03 (0.95-1.11) in never smokers and 0.98 (0.90-1.07) in ever-smokers. For selenium, meta- RRs were 1.09 (0.78-1.52 and 0.76 (0.60-0.96) for never and ever-smokers, respectively; however, results for current smokers were weaker than those for former smokers. Subanalyses according to different exposure assessment methods and outcome definitions produced similar results across strata. Conclusion: The association between vitamin E and prostate cancer is not modified by smoking. Selenium exposure is associated with lower prostate cancer risk among ever-smokers; however, the lack of an association for current smokers indicates that this finding needs to be interpreted with caution.

AB - Background: Epidemiological studies of selenium and vitamin E, two antioxidants hypothesized to reduce prostate cancer risk, have shown no discernible benefit. It has been proposed, however, that tobacco smoking may modify the effect of these nutrients. Materials and Methods: We performed a meta-analysis of studies evaluating the relation of vitamin E and selenium exposure to prostate cancer risk in never smokers vs. ever smokers and, when feasible, former and current smokers. Overall and stratumspecific meta-risk ratios (meta-RRs) and 95% confidence intervals (CIs) were calculated using random-effects models. Results: A total of 21 studies have met the inclusion criteria. Meta-RR (95% CI) estimates of prostate cancer associated with vitamin E use were 1.03 (0.95-1.11) in never smokers and 0.98 (0.90-1.07) in ever-smokers. For selenium, meta- RRs were 1.09 (0.78-1.52 and 0.76 (0.60-0.96) for never and ever-smokers, respectively; however, results for current smokers were weaker than those for former smokers. Subanalyses according to different exposure assessment methods and outcome definitions produced similar results across strata. Conclusion: The association between vitamin E and prostate cancer is not modified by smoking. Selenium exposure is associated with lower prostate cancer risk among ever-smokers; however, the lack of an association for current smokers indicates that this finding needs to be interpreted with caution.

UR - http://www.scopus.com/inward/record.url?scp=84939625284&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939625284&partnerID=8YFLogxK

M3 - Article

VL - 35

SP - 4983

EP - 4996

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 9

ER -

Kim Y, Wei J, Citronberg J, Hartman T, Fedirko V, Goodman M. Relation of Vitamin E and selenium exposure to prostate cancer risk by smoking status: A review and meta-analysis. Anticancer Research. 2015 Sep 1;35(9):4983-4996.